Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumour proliferation and oestrogen receptor status

Journal of Pathology

Volumn 182, Issue 2, 1997, Pages 160-166

  Jares, Pedro ^a   Rey, María J ^b   Fernández, Pedro L ^b,d   Campo, Elías ^b   Nadal, Alfons ^c   Muñoz, Montserrat ^b   Mallofré, Carmen ^b   Muntané, Jaume ^b   Nayach, Iracema ^b   Estapé, Jordi ^b   Cardesa, Antonio ^b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital Casa de Maternitat   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; GENE PRODUCT; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

BLOTTING, NORTHERN; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CYCLIN D1; CYCLINS; FLOW CYTOMETRY; GENE EXPRESSION; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS; RECEPTORS, ESTROGEN;

EID: 0030855167     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199706)182:2<160::AID-PATH814>3.0.CO;2-2     Document Type: Article

References (60)

1. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991; 65: 691-699.
2. Hinds PH, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994; 91: 709-713.
3. Arnold A, Kim HG, Gaz RD, et al. Molecular cloning and chromosomal mapping of DNA rearrangement with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989; 83: 2034-2040.
4. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by BCL1-linked candidate oncogene. Nature 1991; 350: 512-515.
5. Rosenberg CL, Wong E, Petty EM, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991; 88: 9638-9642.
6. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC. Characterization of a candidate bcl-1 gene. Mol Cell Biol 1991; 11: 4846-4853.
7. Bosch F, Jares P, Campo E, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726-2732.
8. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994; 54: 4813-4817.
9. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994; 74: 152-158.
10. Xu L, Davidson BJ, Murty VVVS, et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 1994; 59: 383-387.
11. Jiang W, Zhang Y-J, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993; 90: 9026-9030.
12. Tsuruta H, Sakamoto H, Onda M, Terada M. Amplification and overexpression of EXP1 and EXP2/CYCLIN D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 1993; 196: 1529-1536.
13. Wang LD, Shi ST, Zhou Q, et al. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 1994; 59: 514-519.
14. Berenson JR, Koga H, Yang J, et al. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene 1990; 5: 1343-1348.
15. Zhang Y, Jiang W, Chen CJ, et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993; 196: 1010-1016.
16. Ali IU, Merlo G, Callahan R, Lidereau R. The amplification unit on chromosome l1q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. Oncogene 1989; 4: 89-92.
17. Theillet C, Adnane J, Szepetowski P, et al. BCL-1 participates in the l1q13 amplification found in breast cancer. Oncogene 1990; 5: 147-149.
18. Schuuring E, Verhoeven E, van Tinteren H, et al. Amplification of genes within the chromosome l1q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992; 52: 5229-5234.
19. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993; 90: 1112-1116.
20. Buckley MF, Sweeney KJE, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogen 1993; 8: 2127-2133.
21. Wang TC; Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369: 669-671.
22. Bartkova J, Lukas J, Muller H, Lützhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57: 353-361.
23. Giliet C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812-1817.
24. Adnane J, Gaudray P, Simon M-P, Simony-Lafontaine J, Jeanteur P, Theillet C. Proto-oncogene amplification and human breast tumor phenotype. Oncogene 1989; 4: 1389-1395.
25. Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994; 102: 695-698.
26. Dickson C, Fantl V, Gillett C, et al. Amplification of chromosome band 1lq13 and a role for cyclin D1 in human breast cancer. Cancer Lett 1995; 90: 43-50.
27. Zukerberg LR, Yang WI, Gadd M, et al. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 1995; 8: 560-567.
28. McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11: 885-891.
29. Worsley SD, Jennings BA, Khalil KH, Girling AC. Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression. J Clin Pathol: Mol Pathol 1996; 49: M46-M50.
30. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-778.
31. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993; 73: 499-511.
32. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev 1993; 7: 331-342.
33. Muller H, Lukas J, Schneider A, et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994; 91: 2945-2949.
34. Lee EY-PP, To H, Shew J-Y, Bookstein R, Scully P, Lee W-H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988; 241: 218-221.
35. T'Ang A, Varley JM, Chakraborty S, Murphree AL, Fung Y-KT. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988; 242: 263-266.
36. Sawan A, Randall B, Angus B, et al. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study. J Pathol 1992; 168: 23-28.
37. Tradel M, Mulligan L, Cavenee W, Margolese R, Côté J, Gariépy G, Retinoblastoma and p53 product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 1992; 23: 1388-1394.
38. Berns EM, de Klein A, van Putten WL, et al. Association between RB-1 gene alterations and factors of favorable prognosis in human breast cancer, without effect on survival. Int J Cancer 1995; 64: 140-145.
39. Gjetting T, Lukas J, Bartek J, Strauss M. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control. Biol Chem Hoppe Seyler 1995; 376: 441-446.
40. Elston CW, Ellis OI. Pathology and breast screening, Histopathology 1990; 16: 109-118.
41. Geradts J, Hu S-X, Lincoln CE, Benedict WF, Xu H-J. Aberrant RB gene expression in routinely processed archival tumor tissue determined by three different anti-Rb antibodies. Int J Cancer 1994; 58: 161-167.
42. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985; 109: 716-772.
43. Hedley DW, Friedlander ML, Taylor JW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-1335.
44. Bartkova J, Lukas J, Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994; 172: 237-245.
45. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic irritation factor 4E. Mol Cell Biol 1993; 13: 7358-7363.
46. Tsuda H, Hirohashi S, Hirota T, et al. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 1989; 49: 3104-3108.
47. Borg A, Sigurdsson H, Clark GM, et al. Association of int-2/hst1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 1991; 63: 136-142.
48. Fantl V, Richards MA, Smith R, et al. Gene amplification on chromosome band l1q13 and oestrogen receptor status in breast cancer. Eur J Cancer 1990; 26: 423-429.
49. Lippman ME, Bolan G. Oestrogen-responsive human breast cancer in long term tissue culture. Nature 1975; 256: 592-593.
50. Furuya Y, Kohno N, Fujiwara Y, Saito Y. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in improved culture media. Cancer Res 1989; 49: 6670-6674.
51. Leung BS, Potter AH, Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population. J Cell Biochem 1987; 34: 213-225.
52. Sutherland RL, Watts CKW, Musgrove EA. Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J Steroid Biochem Mol Biol 1993; 47: 99-106.
53. Thompson EW, Martin MB, Saceda M, et al. Regulation of breast cancer cells by hormones and growth factors: effects on proliferation and basement membrane invasiveness. Horm Res 1989; 32(Suppl): 242-249.
54. Musgrove EA, Hamilton JE, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 1993; 13: 3577-3587.
55. Wats CKW, Sweeney KJE, Walters A, Musgrove EA, Sutherland RL. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1994; 31: 95-105.
56. Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclins accelerates G phase in rodent fibroblasts. Genes Dev 1993; 7: 1559-1571.
57. Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 1995; 31A: 329-333.
58. Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 1994; 9: 1633-1640.
59. Lukas J, Muller H, Bartkova J, et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994; 125: 625-638.
60. Schauer IE, Siriwardana S, Langan TA, Sclafani RA. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small lung cancer. Proc Natl Acad Sci USA 1994; 91: 7827-7831.